|
|||||
|
|
Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes |
|
| Authors: | Yoh Zen Yen-Ying Chen Yung-Ming Jeng Hung-Wen Tsai Matthew M Yeh |
| Affiliation: | 1. Institute of Liver Studies, King's College Hospital and King's College London, London, UK;2. Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan School of Medicine, National Yang-Ming University, Taipei, Taiwan;3. Department of Pathology, National Taiwan University, Taipei, Taiwan;4. Department of Pathology, National Cheng-Kung University, Tainan, Taiwan;5. Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA |
| Abstract: | |
| Keywords: | atezolizumab cholangitis hepatitis liver biopsy pembrolizumab |
